The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence
Clemons KV & Stevens DA. (2005) The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence. Med Mycol 43: S101–S110.
Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis
Schmitt HJ, Bernard EM, Hauser M, Amstrong D, Bakker-Woudenberg IAJM & Verbrugh HA. (1988) Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis. Antimicrob Agents Chemother 32: 1676–1679.
Liposomal amphotericin B (Ambisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rat model of pulmonar y aspergillosis
Leenders ACAP, de Marie S & ten Kate MT. (1996) Liposomal amphotericin B (Ambisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rat model of pulmonar y aspergillosis. J Antimicrob Chemother 38: 215–225.
Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model
Becker MJ, de Marie S, Willemse D, Verbrugh HA & Bakker-Woudenberg IAJM. (2000) Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J Clin Microbiol 38: 1434–1438.
The utility of a nebulized intra-tracheal rat model of invasive pulmonary aspergillosis
Chandenier J, Bernard S, Montharu J, Bailly E, Fétissof F, de Monte M, Desoubeaux G, Diot P & Richard-Lenoble D. (2009) The utility of a nebulized intra-tracheal rat model of invasive pulmonary aspergillosis. Mycoses 52: 239–245.
Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment
Morton DB, Griffiths PH. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. (1985) Vet Rec. 20: 431–6.
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
De Pauw B, Walsh TJ, Donnelly JP, et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46: 1813–1821.
